Skip to main content
SpringerLink
Log in

Partielle Drüsenablation mit vaskulär gezielter Phototherapie vs. aktive Überwachung beim Niedrigrisikoprostatakarzinom

Ergebnisse einer randomisierten Studie

Partial gland ablation with vascular-targeted phototherapy versus active surveillance for low-risk prostate cancer

Results of a randomized trial

  • Journal Club
  • Published:
Der Urologe Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Azzouzi AR, Vincendeau S, Barret E, Cicco A, Kleinclauss F, van der Poel HG et al (2017) Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial. Lancet Oncol 18(2):181–191. https://doi.org/10.1016/S1470-2045(16)30661-1

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Prostatakrebszentrum Martini-Klinik, Universitätsklinikum Hamburg Eppendorf, Martinistraße 52, 20246, Hamburg, Deutschland

    G. Salomon

Authors
  1. G. Salomon
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to G. Salomon.

Ethics declarations

Interessenkonflikt

G. Salomon gibt an, dass kein Interessenkonflikt besteht.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Salomon, G. Partielle Drüsenablation mit vaskulär gezielter Phototherapie vs. aktive Überwachung beim Niedrigrisikoprostatakarzinom. Urologe 57, 1496–1498 (2018). https://doi.org/10.1007/s00120-018-0809-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00120-018-0809-x

Search

Navigation